RemeGen Co., Ltd. News

Remegen Biopharmaceutical (Yantai) Co., Ltd. voluntarily disclosed an announcement about Tai.tasirumab achieving the primary study endpoint in Phase III clinical studies of myasthenia gravis.

Aug 14 00:00

Announcement on the Change of Some Senior Management Personnel at Remegen Biopharmaceutical (Yantai) Co., Ltd.

Aug 10 00:00

Remegen's announcement regarding the dilutive immediate return and remedial measures for the issuance of A shares to specific parties in 2024 and relevant commitments of the main entities (revised draft)

Jul 25 00:00

Remegen issued a revised announcement regarding the issuance of A shares to specific objects in 2024.

Jul 25 00:00

Remegen announces the adjustment of its 2024 A-share stock issuance plan for specific targets.

Jul 25 00:00

Remegen's explanation on the use of the raised funds in technology innovation field (Revised draft).

Jul 25 00:00

Feasibility analysis report (revised) for the use of funds raised from the issuance of A shares of Remegen in 2024 to specific objects.

Jul 25 00:00

Revised analysis report on Remegen's A-share stock issuance plan for specific targets in 2024.

Jul 25 00:00

Remegen's plan to issue A shares of stocks to specific entities has been revised for the 2024 fiscal year.

Jul 25 00:00

Remegen's announcement on the revised plan to issue A shares of stocks to specific targets in 2024

Jul 25 00:00

Remegen's Second Supervisory Committee's Eleventh Meeting Resolution Announcement.

Jul 25 00:00

Remegen announces the resolution of the 14th meeting of the second Board of Directors.

Jul 25 00:00

RemeGen Co., Ltd.: Announcement listed in Hong Kong

Jul 23 00:00

Announcement of Progress in Enterprise Shareholding of the Company Controlled by the Actual Controller of Remegen Biopharmaceutical (Yantai) Co., Ltd.

Jul 17 00:00

Remegen Pharma (Yantai) Co., Ltd.'s stocks experienced abnormal fluctuations in trading, according to an announcement.

Jul 11 00:00

Reply to the Inquiry Letter regarding Unusual Fluctuation in Trading of Stocks of Remegen Biopharmaceutical (Yantai) Co., Ltd.

Jul 11 00:00

RemeGen Co., Ltd.: Investor Relations Activity Record Form for July 9th, 2024

Jul 9 18:13

Announcement of Remegen Pharmaceutical (Yantai) Co., Ltd. regarding the plan of the actual controller to increase shareholding in the company.

Jul 9 00:00

Announcement from Remegen regarding change of signed registered accountant

Jul 3 00:00

Legal opinion on the 2023 Remegen annual shareholder meeting.

Jun 29 00:00